Literature DB >> 31853000

Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.

Yangjing Zhao1,2, Qixiang Shao2, Guangyong Peng3,4.   

Abstract

The failure of a massive influx of tumor-infiltrating T lymphocytes to eradicate tumor cells in the tumor microenvironment is mainly due to the dysfunction of T cells hyporesponsive to tumors. T-cell exhaustion and senescence induced by malignant tumors are two important dysfunctional states that coexist in cancer patients, hindering effective antitumor immunity and immunotherapy and sustaining the suppressive tumor microenvironment. Although exhausted and senescent T cells share a similar dysfunctional role in antitumor immunity, they are distinctly different in terms of generation, development, and metabolic and molecular regulation during tumor progression. Here, we discuss the unique phenotypic and functional characteristics of these two types of dysfunctional T cells and their roles in tumor development and progression. In addition, we further discuss the potential molecular and metabolic signaling pathways responsible for the control of T-cell exhaustion and senescence in the suppressive tumor microenvironment. Understanding these critical and fundamental features should facilitate rethinking the unresponsiveness to current immunotherapies in clinical patients and lead to further development of novel and effective strategies that target different types of dysfunctional T cells to enhance cancer immunotherapy.

Entities:  

Keywords:  Checkpoint blockade; Exhaustion; Inhibitory receptor; Metabolism; Senescence; T-cell dysfunction; Tumor microenvironment

Mesh:

Year:  2019        PMID: 31853000      PMCID: PMC6952436          DOI: 10.1038/s41423-019-0344-8

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  133 in total

1.  Antitumor CD8+ T cells in hepatocellular carcinoma: present but exhausted.

Authors:  Ka-Kit Li; David H Adams
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 2.  The three main stumbling blocks for anticancer T cells.

Authors:  Lukas Baitsch; Silvia A Fuertes-Marraco; Amandine Legat; Christiane Meyer; Daniel E Speiser
Journal:  Trends Immunol       Date:  2012-03-23       Impact factor: 16.687

Review 3.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 4.  Immunosuppressive networks in the tumour environment and their therapeutic relevance.

Authors:  Weiping Zou
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.

Authors:  Steven A Rosenberg; Richard M Sherry; Kathleen E Morton; William J Scharfman; James C Yang; Suzanne L Topalian; Richard E Royal; Udai Kammula; Nicholas P Restifo; Marybeth S Hughes; Douglas Schwartzentruber; David M Berman; Susan L Schwarz; Lien T Ngo; Sharon A Mavroukakis; Donald E White; Seth M Steinberg
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

Review 6.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Authors:  Andrea Schietinger; Philip D Greenberg
Journal:  Trends Immunol       Date:  2013-11-06       Impact factor: 16.687

Review 7.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

Authors:  Mojgan Ahmadzadeh; Laura A Johnson; Bianca Heemskerk; John R Wunderlich; Mark E Dudley; Donald E White; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

Review 9.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.

Authors:  Helena Harlin; Todd V Kuna; Amy C Peterson; Yuru Meng; Thomas F Gajewski
Journal:  Cancer Immunol Immunother       Date:  2006-02-09       Impact factor: 6.968

View more
  62 in total

Review 1.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

Review 2.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

3.  Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.

Authors:  Jessica Beck; Casmir Turnquist; Izumi Horikawa; Curtis Harris
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

Review 4.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 5.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

6.  Notch signaling defects in NK cells in patients with cancer.

Authors:  Gulnur K Zakiryanova; Elena Kustova; Nataliya T Urazalieva; Emile T Baimukhametov; Valeriy A Makarov; Gulmariya M Turaly; Galina V Shurin; Zarema M Biyasheva; Narymzhan N Nakisbekov; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2020-10-21       Impact factor: 6.968

Review 7.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

Review 8.  Aging and Options to Halt Declining Immunity to Virus Infections.

Authors:  Miguel Ángel Palacios-Pedrero; Albert D M E Osterhaus; Tanja Becker; Husni Elbahesh; Guus F Rimmelzwaan; Giulietta Saletti
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

9.  NK and NKT cells have distinct properties and functions in cancer.

Authors:  Xia Liu; Lingyun Li; Fusheng Si; Lan Huang; Yangjing Zhao; Chenchen Zhang; Daniel F Hoft; Guangyong Peng
Journal:  Oncogene       Date:  2021-06-12       Impact factor: 9.867

10.  Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction.

Authors:  Rémi Bunet; Manon Nayrac; Hardik Ramani; Mohamed Sylla; Madeleine Durand; Carl Chartrand-Lefebvre; Jean-Pierre Routy; Alan L Landay; Jean-Francois Gauchat; Nicolas Chomont; Petronela Ancuta; Daniel E Kaufmann; Nicole Bernard; Cécile L Tremblay; Mohamed El-Far
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.